Vietnam licenses Pfizer COVID-19 vaccine for emergency use
VOV.VN - The Ministry of Health has approved the Pfizer coronavirus vaccine Comirnaty for emergency use in Vietnam on request from Pfizer Vietnam Co. Ltd.
The decision on conditional approval for the Comirnaty vaccine was signed by Deputy Minister of Health Tran Van Thuan on June 12.
Comirnaty is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people aged 12 years and older. It contains a molecule called messenger RNA (mRNA) with instructions for producing a protein from SARS-CoV-2, the virus that causes COVID-19.
The vaccine is produced at Pfizer Manufacturing Belgium NV, Belgium, and BioNTech Manufacturing GmbH, Germany.
Pfizer/BioNtech’s Comirnaty vaccine is the fourth COVID-19 vaccine to be imported to Vietnam, after the AstraZeneca vaccine of the United Kingdom, Sputnik V vaccine of Russia and Sinopharm vaccine of China.
Developed since early 2020, the vaccine has been approved by the World Health Organization based on its safety and immunogenicity records. The vaccine has been used widely in the United States and the European Union.
Vietnam has recently reached an agreement to purchase 31 million doses of the Pfizer/BioNtech, and the first batch is expected to arrive before July 2021.
